#United States #San Diego #Robbins LLP #Securities Fraud #LifeMD

Investors Advised to Act Before Class Action Deadline for LifeMD

LifeMD, Inc. (NASDAQ: LFMD), a prominent provider of virtual primary healthcare, is currently facing a class action lawsuit that has implications for its shareholders. Filed on behalf of investors who acquired LifeMD securities between May 7, 2025, and August 5, 2025, this lawsuit is centered on allegations of misleading investors about the company’s operational prospects and financial guidance.

Background of the Allegations

Robbins LLP, a well-regarded firm specializing in shareholder rights litigation, has informed stockholders that during the specified class period, LifeMD's leadership purportedly exaggerated the company’s competitive standing. The filed complaint claims that executives raised revenue projections recklessly without adequately accounting for the escalating customer acquisition costs within the company’s RexMD division and those related to appetite-suppressing drugs. Consequently, the statements issued by LifeMD regarding its business status and forecasts were deemed materially false and misleading, lacking a reasonable basis.

The situation culminated on August 5, 2025, when LifeMD released its second-quarter financial results, which prompted a significant stock price drop of over 44%. The company described facing temporary nuances in its RexMD business but still anticipated robust growth in revenue and adjusted EBITDA for the year.

Participation and Legal Rights for Shareholders

For LifeMD shareholders, this is an important moment, as they have the option to join the class action which aims to hold the company accountable for these alleged misrepresentations. Those interested in taking a leading role must file their papers with the court by October 27, 2025. Notably, becoming a lead plaintiff also entails acting as a representative for other affected stockholders. However, stakeholders may also opt to remain as absent class members without taking any action.

An important aspect of this litigation is that all legal representation is arranged on a contingency basis. This means that shareholders do not incur any upfront legal fees or expenses as they seek to reclaim losses incurred due to LifeMD's alleged securities violations.

About Robbins LLP

Established in 2002, Robbins LLP has built a reputation for advocating on behalf of shareholders, helping them recover losses, improve governance structures, and hold company executives accountable for any misconduct. They underscore a commitment to fostering a fair corporate environment, actively engaging with stockholders to raise awareness of significant corporate governance issues.

For those impacted and seeking further insights about their rights and options in light of the LifeMD allegations, Robbins LLP encourages reaching out directly via phone or by submitting queries through their website.

Investors are urged, especially with the lead plaintiff deadline fast approaching, to be proactive in understanding their position in this class action and ensuring they secure their rightful interests. This is a pivotal moment for shareholders of LifeMD, and acting now could prove significant in the pursuit of justice if the allegations are substantiated.